Smruthi Organic

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE172E01011
  • NSEID:
  • BSEID: 540686
INR
128.75
2.1 (1.66%)
BSENSE

Dec 05

BSE+NSE Vol: 55

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

55 (-52.34%) Volume

Shareholding (Sep 2025)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

64.73%

When is the next results date for Smruthi Organic?

06-Jun-2025

No Upcoming Board Meetings

Who are in the management team of Smruthi Organic?

06-Jun-2025

As of March 2023, the management team of Smruthi Organic includes E Purushotham (Chairman & Managing Director), E Swapnil (Joint Managing Director & CFO), and several independent directors, along with a Company Secretary. They oversee the company's operations and strategic direction.

As of March 2023, the management team of Smruthi Organic includes:<BR><BR>1. E Purushotham - Chairman & Managing Director<BR>2. E Swapnil - Joint Managing Director & CFO<BR>3. J H Ranade - Independent Director<BR>4. K Ramaswamy - Independent Director<BR>5. Kashinath R Dhole - Independent Director<BR>6. Urvashi D Khanna - Company Secretary & Compliance Officer<BR>7. E. Smruthi - Non-Executive & Non-Independent Director<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

Read More

What is the bonus history of the Smruthi Organic?

06-Jun-2025

Smruthi Organic announced a 2:1 bonus issue on March 16, 2021, with a record date of March 17, 2021, allowing shareholders to receive two additional shares for every one share held.

Smruthi Organic has a bonus history that includes a 2:1 bonus issue announced on March 16, 2021. The record date for this bonus was March 17, 2021. This means that shareholders received two additional shares for every one share they held as of the record date. If you have any more questions about the company or its financial activities, feel free to ask!

Read More

Has Smruthi Organic declared dividend?

06-Jun-2025

Yes, Smruthi Organics Ltd has declared a 15% dividend, amounting to ₹1.5 per share, with an ex-date of June 13, 2025. Despite recent volatility, the company has shown a strong recovery over the past five years, yielding a total return of 279.01%.

Smruthi Organics Ltd has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 15%<BR>- Amount per share: 1.5<BR>- Ex-date: 13 Jun 25<BR><BR>Dividend Yield: 1.16%<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -1.08%, the dividend return was 1.17%, resulting in a total return of 0.09%.<BR><BR>Over the past year, the price return was -21.76%, with a dividend return of 1.75%, leading to a total return of -20.01%.<BR><BR>In the 2-year period, the price return was -12.23%, while the dividend return was 3.86%, resulting in a total return of -8.37%.<BR><BR>For the 3-year period, the price return was -27.96%, the dividend return was 5.03%, culminating in a total return of -22.93%.<BR><BR>In the last 4 years, the price return was -50.94%, with a dividend return of 3.54%, resulting in a total return of -47.4%.<BR><BR>Finally, over the 5-year period, the price return was 252.55%, the dividend return was 26.46%, leading to a total return of 279.01%.<BR><BR>Overall, while Smruthi Organics Ltd has declared a dividend, the total returns over various periods show significant volatility, with negative returns in most periods except for the 5-year period, which indicates a strong recovery in the long term.

Read More

Who are the peers of the Smruthi Organic?

03-Jun-2025

Smruthi Organic's peers include Sun Pharma, Divi's Lab, Cipla, Torrent Pharma, Dr Reddy's Labs, and others. In terms of performance, Smruthi Organic has a 1-year return of -22.54%, with growth and management risk rated below average compared to its peers.

Peers: The peers of Smruthi Organic are Sun Pharma.Inds., Divi's Lab., Cipla, Torrent Pharma, Dr Reddy's Labs, Denis Chem Lab, BDH Industries, Tyche Industries, Quest, and Sotac Pharma.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sun Pharma.Inds., Cipla, Dr Reddy's Labs, BDH Industries, Tyche Industries, and Quest, while Average management risk is found at Denis Chem Lab. Growth is excellent at Sun Pharma.Inds., Cipla, and Dr Reddy's Labs, while below average growth is noted for Divi's Lab., Torrent Pharma, Smruthi Organic, Denis Chem Lab, BDH Industries, and Tyche Industries. Excellent capital structure is seen in Sun Pharma.Inds., Cipla, Dr Reddy's Labs, Smruthi Organic, Denis Chem Lab, BDH Industries, Tyche Industries, and the rest.<BR><BR>Return Snapshot: Divi's Lab. has the highest 1-year return at 51.96%, while Denis Chem Lab has the lowest at -38.43%. Smruthi Organic's 1-year return is -22.54%, which is significantly lower than Divi's Lab. and higher than Denis Chem Lab. Additionally, BDH Industries, Tyche Industries, and Denis Chem Lab have negative six-month returns.

Read More

Is Smruthi Organic overvalued or undervalued?

09-Jun-2025

As of May 6, 2025, Smruthi Organic is considered undervalued with a PE ratio of 41.20 and an attractive valuation compared to peers, despite a recent 1-year return of -19.68%, while maintaining a strong long-term outlook with a 5-year return of 311.48%.

As of 6 May 2025, the valuation grade for Smruthi Organic has moved from expensive to attractive, indicating a shift in market perception. The company is currently assessed as undervalued. Key ratios include a PE ratio of 41.20, an EV to EBITDA of 13.44, and a PEG ratio of 0.00, which suggests potential for growth relative to its price.<BR><BR>In comparison to its peers, Smruthi Organic's PE ratio is higher than Sun Pharma's 35.25 but lower than Divi's Lab's significantly high 79.33. Additionally, while Cipla has an attractive valuation with an EV to EBITDA of 15.93, Smruthi's lower EV to EBITDA indicates it may be undervalued relative to its earnings potential. Notably, despite recent underperformance with a 1-year return of -19.68% compared to the Sensex's 7.62%, the long-term outlook remains positive with a 5-year return of 311.48%.

Read More

What is the technical trend for Smruthi Organic?

09-Jun-2025

As of May 12, 2025, Smruthi Organic's trend is mildly bearish, with conflicting signals from weekly indicators showing mild bullishness and monthly indicators remaining bearish.

As of 12 May 2025, the technical trend for Smruthi Organic has changed from bearish to mildly bearish. The weekly MACD and KST are both mildly bullish, indicating some positive momentum, while the monthly MACD and KST remain bearish. The Bollinger Bands also show a mildly bullish stance on the weekly timeframe but are bearish on the monthly. Daily moving averages indicate a mildly bearish trend. Overall, the current stance is mildly bearish, driven primarily by the conflicting signals between the weekly and monthly indicators.

Read More

What does Smruthi Organic do?

17-Jul-2025

Smruthi Organics Ltd is a Micro Cap company in the Pharmaceuticals & Biotechnology industry, reporting net sales of 381 Cr and a net profit of 22 Cr for the quarter ending March 2025. The company, incorporated in 1989, has a market cap of INR 143 Cr and key metrics including a P/E of 40.00 and a dividend yield of 2.41%.

Overview: <BR>Smruthi Organics Ltd operates in the Pharmaceuticals & Biotechnology industry and is classified as a Micro Cap company.<BR><BR>History: <BR>Smruthi Organics Limited was incorporated in July 1989 as a Private Limited Company and was subsequently converted into a Public Limited Company in February 1995. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 381 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 22 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: INR 143 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 40.00 <BR>Industry P/E: 37 <BR>Dividend Yield: 2.41% <BR>Debt-Equity: 0.23 <BR>Return on Equity: 4.98% <BR>Price to Book: 1.99 <BR><BR>Contact Details: <BR>Address: 165-A Balaji Bhavan 1st Floor, Railway Lines Solapur Maharashtra : 413001 <BR>Tel: 91-217-2310267/2310268 <BR>Email: changale@smruthiorganics.com <BR>Website: http://www.smruthiorganics.com

Read More

Who are the top shareholders of the Smruthi Organic?

17-Jul-2025

The top shareholders of Smruthi Organic are mainly promoters, with Eaga Purushotham Malaiah holding 41.23%. The highest public shareholder is Smitha Gupta at 1.21%, while individual investors collectively own 28.81% of the shares.

The top shareholders of Smruthi Organic are primarily the promoters, with Eaga Purushotham Malaiah holding the largest stake at 41.23%. There are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors (FIIs) holding shares. The highest public shareholder is Smitha Gupta, who owns 1.21%. Additionally, individual investors collectively hold 28.81% of the shares.

Read More

How big is Smruthi Organic?

24-Jul-2025

As of 24th July, Smruthi Organics Ltd has a market capitalization of 147.00 Cr, with Net Sales of 126.00 Cr and a Net Profit of 3.57 Cr reported in the latest four quarters. The company has Shareholder's Funds of 71.63 Cr and Total Assets of 111.74 Cr for the annual period ending March 2025.

As of 24th July, Smruthi Organics Ltd has a market capitalization of 147.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Smruthi Organics reported Net Sales of 126.00 Cr and a Net Profit of 3.57 Cr.<BR><BR>For the latest annual period ending March 2025, the company has Shareholder's Funds amounting to 71.63 Cr and Total Assets of 111.74 Cr.

Read More

Are Smruthi Organic latest results good or bad?

11-Nov-2025

Smruthi Organic's latest Q1 FY26 results are poor, showing a net loss of ₹1.10 crore and a 50.14% drop in revenue compared to the previous quarter, indicating significant operational challenges and declining profitability.

Smruthi Organic's latest results for Q1 FY26 indicate a challenging financial performance. The company reported a net loss of ₹1.10 crore, a significant decline compared to a profit of ₹2.23 crore in the previous quarter (Q4 FY25). Revenue also fell sharply, down 50.14% quarter-on-quarter and 30.36% year-on-year, totaling ₹18.99 crore. This revenue drop reflects severe operational challenges and volatility.<BR><BR>The operating margin has drastically reduced to just 1.21% from 12.26% in the prior quarter, highlighting significant margin pressure. Additionally, the return on equity (ROE) has declined to 4.73%, down from an average of 12.04% over the past five years, indicating weakening shareholder value creation.<BR><BR>Overall, these results suggest that Smruthi Organic is currently facing substantial difficulties, with both profitability and revenue showing negative trends. The financial performance raises concerns about the company's operational stability and long-term growth prospects.

Read More

How has been the historical performance of Smruthi Organic?

17-Nov-2025

Smruthi Organic's historical performance shows declining net sales and total operating income from INR 141.04 crore in March 2023 to INR 126.01 crore in March 2025, despite a decrease in raw material costs and an increase in operating profit. Overall, the company has faced mixed financial results with fluctuating profits and cash flow.

Answer:<BR>The historical performance of Smruthi Organic shows a fluctuating trend in key financial metrics over the past several years.<BR><BR>Breakdown:<BR>Smruthi Organic's net sales have seen a decline from INR 141.04 crore in March 2023 to INR 126.01 crore in March 2025, with a peak in March 2023. The total operating income followed a similar trend, dropping from INR 141.04 crore in March 2023 to INR 126.01 crore in March 2025. The raw material costs decreased significantly from INR 95.69 crore in March 2023 to INR 67.86 crore in March 2025, contributing to a reduction in total expenditure, which fell from INR 131.26 crore in March 2023 to INR 113.83 crore in March 2025. Operating profit (PBDIT) has also fluctuated, reaching INR 12.27 crore in March 2025, up from INR 9.89 crore in March 2023. However, profit before tax showed a slight increase from INR 4.49 crore in March 2023 to INR 4.90 crore in March 2025, while profit after tax decreased from INR 4.13 crore in March 2023 to INR 3.56 crore in March 2025. The company's total assets increased from INR 105.64 crore in March 2023 to INR 111.74 crore in March 2025, while total liabilities rose from INR 105.64 crore to INR 111.74 crore in the same period. Cash flow from operating activities improved to INR 9.00 crore in March 2025 from INR 12.00 crore in March 2023, indicating a mixed performance in cash generation. Overall, Smruthi Organic's financial performance reflects a challenging environment with varying trends in sales, profits, and expenses.

Read More

Should I buy, sell or hold Smruthi Organic?

19-Nov-2025

Why is Smruthi Organic falling/rising?

04-Dec-2025

As of 04-Dec, Smruthi Organics Ltd's stock price is at 126.65, reflecting a decline of 2.95% after two days of gains. The stock has underperformed its sector and the Sensex over various periods, indicating a bearish trend despite a slight increase in investor participation.

As of 04-Dec, Smruthi Organics Ltd's stock price is falling, currently at 126.65, which reflects a decrease of 3.85 or 2.95%. This decline follows a trend reversal after two consecutive days of gains. The stock has underperformed its sector by 3.24% today and reached an intraday low of Rs 125, marking a drop of 4.21%. <BR><BR>In terms of performance over different periods, the stock has shown a negative return of 2.58% over the past month and a decline of 1.44% over the past year, contrasting with the Sensex, which has gained 2.16% and 5.32% in the same periods, respectively. Additionally, over the last three years, the stock has significantly underperformed with a drop of 32.11%, while the Sensex has risen by 35.62%.<BR><BR>Despite a slight increase in investor participation, with delivery volume rising by 11.71% against the five-day average, the stock's moving averages indicate a bearish trend, being lower than the 5-day, 20-day, 50-day, and 100-day moving averages, although it remains higher than the 200-day moving average. Overall, these factors contribute to the current decline in Smruthi Organics Ltd's stock price.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Company has a low Debt to Equity ratio (avg) at 0.10 times

 
2

Poor long term growth as Net Sales has grown by an annual rate of -1.13% and Operating profit at -12.59% over the last 5 years

3

With ROCE of 10.5, it has a Attractive valuation with a 1.9 Enterprise value to Capital Employed

4

Majority shareholders : Promoters

 
5

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 147 Cr (Micro Cap)

stock-summary
P/E

31.00

stock-summary
Industry P/E

34

stock-summary
Dividend Yield

1.18%

stock-summary
Debt Equity

0.11

stock-summary
Return on Equity

6.60%

stock-summary
Price to Book

2.05

Revenue and Profits:
Net Sales:
32 Cr
(Quarterly Results - Sep 2025)
Net Profit:
2 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (1.18%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
12.01%
0%
12.01%
6 Months
-0.19%
1.16%
0.97%
1 Year
-0.96%
1.22%
0.26%
2 Years
-28.15%
1.75%
-26.4%
3 Years
-32.64%
3.00%
-29.64%
4 Years
-51.05%
2.86%
-48.19%
5 Years
3.75%
6.98%
10.73%

Latest dividend: 1.5 per share ex-dividend date: Jun-13-2025

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News

Why is Smruthi Organic falling/rising?

Recent Price Movement and Market Context

Smruthi Organics’ share price fell by 0.82% on 21 November, underperforming its sector by 0.3%. Although the stock touched an intraday high of ₹131.7, marking a 2.37% gain during the session, it ultimately closed lower. This intraday volatility suggests some buying interest, but selling pressure prevailed by the end of trading hours.

When compared to the broader market, the stock’s recent returns have lagged significantly. Over the past week, Smruthi Organics declined by 2.60%, while the Sensex gained 0.79%. Similarly, over the last month, the stock dropped 6.07%, contrasting with a 0.95% rise in the benchmark. Year-to-date, the stock has delivered a modest 6.56% gain, trailing the Sensex’s 9.08% advance. Over longer horizons, t...

Read More
Announcements stock-summary

Announcement under Regulation 30 (LODR)-Newspaper Publication

12-Nov-2025 | Source : BSE

Newspaper Publication

Board Meeting Outcome for Quarterly Results For Second Quarter And Half Year Ended 30Th September 2025

11-Nov-2025 | Source : BSE

Quarterly Results for second quarter and half year ended 30th September 2025

Financial Results For Quarter And Half Year Ended 30Th September 2025

11-Nov-2025 | Source : BSE

Financial Results

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Smruthi Organics Ltd has declared 15% dividend, ex-date: 13 Jun 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Smruthi Organics Ltd has announced 2:1 bonus issue, ex-date: 16 Mar 21

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-1.13%
EBIT Growth (5y)
-12.59%
EBIT to Interest (avg)
8.14
Debt to EBITDA (avg)
0.84
Net Debt to Equity (avg)
0.11
Sales to Capital Employed (avg)
1.72
Tax Ratio
25.95%
Dividend Payout Ratio
48.19%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
15.98%
ROE (avg)
9.85%
Valuation key factors
Factor
Value
P/E Ratio
31
Industry P/E
34
Price to Book Value
2.05
EV to EBIT
18.49
EV to EBITDA
10.88
EV to Capital Employed
1.94
EV to Sales
1.28
PEG Ratio
0.05
Dividend Yield
1.18%
ROCE (Latest)
10.49%
ROE (Latest)
6.60%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Eaga Purushotham Malaiah (41.23%)

Highest Public shareholder

None

Individual Investors Holdings

28.86%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 66.40% vs -50.14% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 287.27% vs -149.33% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "31.60",
          "val2": "18.99",
          "chgp": "66.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.01",
          "val2": "0.23",
          "chgp": "2,078.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.66",
          "val2": "0.46",
          "chgp": "43.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "2.06",
          "val2": "-1.10",
          "chgp": "287.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.85%",
          "val2": "1.21%",
          "chgp": "14.64%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -10.71% vs -12.16% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 740.00% vs -103.44% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "50.59",
          "val2": "56.66",
          "chgp": "-10.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.24",
          "val2": "3.34",
          "chgp": "56.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.12",
          "val2": "0.85",
          "chgp": "31.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.96",
          "val2": "-0.15",
          "chgp": "740.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.36%",
          "val2": "5.89%",
          "chgp": "4.47%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -0.08% vs -15.61% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -35.75% vs -39.83% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "87.91",
          "val2": "87.98",
          "chgp": "-0.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7.50",
          "val2": "7.86",
          "chgp": "-4.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.36",
          "val2": "1.04",
          "chgp": "30.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.33",
          "val2": "2.07",
          "chgp": "-35.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "8.53%",
          "val2": "8.93%",
          "chgp": "-0.40%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is -1.28% vs -9.50% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -0.84% vs -13.08% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "126.01",
          "val2": "127.64",
          "chgp": "-1.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "12.18",
          "val2": "11.95",
          "chgp": "1.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.87",
          "val2": "1.41",
          "chgp": "32.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "3.56",
          "val2": "3.59",
          "chgp": "-0.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.67%",
          "val2": "9.36%",
          "chgp": "0.31%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Sep'25 - QoQstock-summary
Sep'25
Jun'25
Change(%)
Net Sales
31.60
18.99
66.40%
Operating Profit (PBDIT) excl Other Income
5.01
0.23
2,078.26%
Interest
0.66
0.46
43.48%
Exceptional Items
0.00
0.00
Standalone Net Profit
2.06
-1.10
287.27%
Operating Profit Margin (Excl OI)
15.85%
1.21%
14.64%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Sep 2025 is 66.40% vs -50.14% in Jun 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is 287.27% vs -149.33% in Jun 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary
Sep'25
Sep'24
Change(%)
Net Sales
50.59
56.66
-10.71%
Operating Profit (PBDIT) excl Other Income
5.24
3.34
56.89%
Interest
1.12
0.85
31.76%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.96
-0.15
740.00%
Operating Profit Margin (Excl OI)
10.36%
5.89%
4.47%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is -10.71% vs -12.16% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is 740.00% vs -103.44% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
87.91
87.98
-0.08%
Operating Profit (PBDIT) excl Other Income
7.50
7.86
-4.58%
Interest
1.36
1.04
30.77%
Exceptional Items
0.00
0.00
Standalone Net Profit
1.33
2.07
-35.75%
Operating Profit Margin (Excl OI)
8.53%
8.93%
-0.40%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -0.08% vs -15.61% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is -35.75% vs -39.83% in Dec 2023

Annual Results Snapshot (Standalone) - Mar'25stock-summary
Mar'25
Mar'24
Change(%)
Net Sales
126.01
127.64
-1.28%
Operating Profit (PBDIT) excl Other Income
12.18
11.95
1.92%
Interest
1.87
1.41
32.62%
Exceptional Items
0.00
0.00
Standalone Net Profit
3.56
3.59
-0.84%
Operating Profit Margin (Excl OI)
9.67%
9.36%
0.31%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is -1.28% vs -9.50% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is -0.84% vs -13.08% in Mar 2024

stock-summaryCompany CV
About Smruthi Organics Ltd stock-summary
stock-summary
Smruthi Organics Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Smruthi Organics Limited was incorporated in July, 1989 as a Private Limited Company and was subsequently converted into a Public Limited Company in February, 1995. The Company was promoted by E Purushotham and Shankarrao R Myakal.
Company Coordinates stock-summary
Company Details
165-A Balaji Bhavan 1st Floor, Railway Lines Solapur Maharashtra : 413001
stock-summary
Tel: 91-217-2310267/2310268
stock-summary
changale@smruthiorganics.com
Registrar Details
Adroit Corporate Services Pvt Ltd, 17-20 Jaferbhoy Industrial Estate , 1st Floor, Makwana Road, Marol Naka, Mumbai